GB2578557B - Enhancement of osteogenic potential of bone grafts - Google Patents

Enhancement of osteogenic potential of bone grafts Download PDF

Info

Publication number
GB2578557B
GB2578557B GB2001056.7A GB202001056A GB2578557B GB 2578557 B GB2578557 B GB 2578557B GB 202001056 A GB202001056 A GB 202001056A GB 2578557 B GB2578557 B GB 2578557B
Authority
GB
United Kingdom
Prior art keywords
enhancement
bone grafts
osteogenic potential
osteogenic
potential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB2001056.7A
Other languages
English (en)
Other versions
GB202001056D0 (en
GB2578557A (en
Inventor
Helms Jill
Dhamdhere Girija
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of GB202001056D0 publication Critical patent/GB202001056D0/en
Publication of GB2578557A publication Critical patent/GB2578557A/en
Application granted granted Critical
Publication of GB2578557B publication Critical patent/GB2578557B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/365—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
GB2001056.7A 2013-07-16 2014-07-16 Enhancement of osteogenic potential of bone grafts Expired - Fee Related GB2578557B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361957946P 2013-07-16 2013-07-16
GB1600149.7A GB2530224B (en) 2013-07-16 2014-07-16 Enhancement of osteogenic potential of bone grafts

Publications (3)

Publication Number Publication Date
GB202001056D0 GB202001056D0 (en) 2020-03-11
GB2578557A GB2578557A (en) 2020-05-13
GB2578557B true GB2578557B (en) 2020-09-02

Family

ID=52346837

Family Applications (2)

Application Number Title Priority Date Filing Date
GB2001056.7A Expired - Fee Related GB2578557B (en) 2013-07-16 2014-07-16 Enhancement of osteogenic potential of bone grafts
GB1600149.7A Expired - Fee Related GB2530224B (en) 2013-07-16 2014-07-16 Enhancement of osteogenic potential of bone grafts

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1600149.7A Expired - Fee Related GB2530224B (en) 2013-07-16 2014-07-16 Enhancement of osteogenic potential of bone grafts

Country Status (12)

Country Link
US (4) US9301980B2 (cg-RX-API-DMAC7.html)
EP (1) EP3021943B1 (cg-RX-API-DMAC7.html)
JP (2) JP6557659B2 (cg-RX-API-DMAC7.html)
KR (1) KR102307174B1 (cg-RX-API-DMAC7.html)
CN (2) CN105431202B (cg-RX-API-DMAC7.html)
AU (2) AU2014290042B2 (cg-RX-API-DMAC7.html)
CA (1) CA2916898A1 (cg-RX-API-DMAC7.html)
GB (2) GB2578557B (cg-RX-API-DMAC7.html)
IL (1) IL243288B (cg-RX-API-DMAC7.html)
MX (1) MX2016000464A (cg-RX-API-DMAC7.html)
WO (1) WO2015009829A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201600095B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017023542A1 (en) 2015-07-31 2017-02-09 DePuy Synthes Products, Inc. Method of preparing an osteogenic bone graft
US11491262B2 (en) * 2018-04-19 2022-11-08 Paulo Jose PASQUALI Method of bone regeneration
EP3787645A4 (en) * 2018-05-02 2022-06-01 Ortheus, Inc. SYSTEMS AND METHODS FOR LOCAL MODULATION OF WNT SIGNALING
CN111700881B (zh) * 2020-07-02 2021-05-18 四川大学 Wnt蛋白\ZIF-8纳米复合体、其制备方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120115788A1 (en) * 2010-09-09 2012-05-10 Jill Helms Use of liposomal WNT composition to enhance Osseointegration

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550289A (en) 1985-01-07 1996-08-27 Syntex (U.S.A.) Inc. N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
US5705655A (en) 1992-12-17 1998-01-06 Megabios Corporation Amphiphilic nitrogen containing imidazolinium derivative compounds and uses
KR960705798A (ko) 1993-11-24 1996-11-08 벤자민 에프 맥그로우 피페라진의 양쪽친화성 유도체(amphiphilic derivatives of piperazine)
KR960705771A (ko) 1993-11-24 1996-11-08 벤자민 에프 맥그로우 구아니딘의 양쪽친화성 유도체(amphiphilic derivatives of guanidine)
CA2194221C (en) 1994-06-22 2001-01-02 Megabios Corporation Cationic amphiphiles
DE19521412A1 (de) 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
JP2004507236A (ja) * 2000-08-18 2004-03-11 プロスケリア 骨粗鬆症の診断および治療に有用な調節遺伝子および系
US6723131B2 (en) * 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
EP1660663A4 (en) * 2003-08-12 2007-07-11 Brigham & Womens Hospital METHOD AND COMPOSITIONS FOR TISSUE REPAIR
US8343922B2 (en) * 2004-05-19 2013-01-01 Enzo Biochem, Inc. Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
CN1846793B (zh) * 2005-04-14 2011-08-03 南方医院 一种组织工程骨及其构建与应用
WO2008109119A2 (en) * 2007-03-05 2008-09-12 The Board Of Trustees Of The Leland Stanford Junior University Wnt compositions and methods of use thereof
JP5458238B2 (ja) * 2007-11-30 2014-04-02 一郎 小野 臓器再生用デバイス
US9526737B2 (en) 2007-12-03 2016-12-27 The Regents Of The University Of California Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
SI2331109T1 (sl) * 2008-08-22 2013-10-30 Anthrogenesis Corporation Postopki in sestavki za zdravljenje okvar kosti s populacijami placentarnih celic
WO2010111278A1 (en) * 2009-03-23 2010-09-30 The Texas A&M University System Compositions of mesenchymal stem cells to regenerate bone
WO2012135176A2 (en) * 2011-03-28 2012-10-04 The Board Of Trustees Of The Leland Stanford Junior University The use of wnt agents to prevent hypoxic injury

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120115788A1 (en) * 2010-09-09 2012-05-10 Jill Helms Use of liposomal WNT composition to enhance Osseointegration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cold Spring Harb Perspect Biol., Vol.4, No. 11, Nov. 2012, KM Cadigan et al., "TCF/LEFs and Wnt signaling in the nucleus.", pii: a007906, pages 1-22. *

Also Published As

Publication number Publication date
CN105431202B (zh) 2020-03-24
CA2916898A1 (en) 2015-01-22
ZA201600095B (en) 2021-09-29
JP6897996B2 (ja) 2021-07-07
EP3021943B1 (en) 2023-09-13
GB202001056D0 (en) 2020-03-11
AU2019222935B2 (en) 2021-09-09
IL243288B (en) 2021-01-31
JP2016524989A (ja) 2016-08-22
US9301980B2 (en) 2016-04-05
EP3021943A2 (en) 2016-05-25
US11771803B2 (en) 2023-10-03
US20180140743A1 (en) 2018-05-24
US20170056556A1 (en) 2017-03-02
AU2019222935A1 (en) 2019-09-19
GB2578557A (en) 2020-05-13
KR20160032125A (ko) 2016-03-23
AU2014290042B2 (en) 2019-06-20
JP6557659B2 (ja) 2019-08-07
CN111643733B (zh) 2023-07-28
CN105431202A (zh) 2016-03-23
US20200147267A1 (en) 2020-05-14
IL243288A0 (en) 2016-02-29
US20150050249A1 (en) 2015-02-19
WO2015009829A3 (en) 2015-11-12
MX2016000464A (es) 2016-04-07
US10568989B2 (en) 2020-02-25
KR102307174B1 (ko) 2021-10-01
AU2014290042A1 (en) 2016-01-28
EP3021943A4 (en) 2017-02-15
GB201600149D0 (en) 2016-02-17
CN111643733A (zh) 2020-09-11
GB2530224A (en) 2016-03-16
JP2019177224A (ja) 2019-10-17
US9925304B2 (en) 2018-03-27
GB2530224B (en) 2020-08-05
WO2015009829A2 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
IL266651B (en) graft
SG11201601412XA (en) Compositions and methods for the treatment of presbyopia
GB2512063B (en) Spinal implant assembly
SG11201600707QA (en) Substituted aminopyrimidine compounds and methods of use
SG10201708595YA (en) Cenicriviroc compositions and methods of making and using the same
GB2541833B (en) Improvements to implant surfaces
PL3071230T3 (pl) Kompozycje do leczenia reumatoidalnego zapalenia stawów oraz sposoby ich stosowania
EP3041485A4 (en) Cell-seeded compositions and methods useful for treating bone regions
GB201507664D0 (en) Composition & methods of screening
IL239893A0 (en) Preparations including 15-ohepa and methods of using them
GB201319531D0 (en) Composition & methods of screening
ZA201508515B (en) Treatment of coal
IL244621A (en) Preparations for the treatment of hypertension and / or fibrosis
IL244622A0 (en) Preparations for the treatment of hypertension and/or fibrosis
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
PL2983725T3 (pl) Cementy akrylowe do wypełniania ubytków tkanki kostnej
ZA201600095B (en) Enhancement of osteogenic potential of bone grafts
PT3071230T (pt) Composições para o tratamento da artrite reumatoide e métodos de utilização das mesmas
IL255363A0 (en) Prosthetic strap
GB201302143D0 (en) Bone reponator
EP3036348A4 (en) Treatment of high sulphur solids
AU2013903136A0 (en) Treatment of High Sulphur Solids
IL230230A0 (en) graft
GB201310756D0 (en) Implant

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20240716